Mesenchymal stromal cells to treat patients with non-ischaemic heart failure: Results from SCIENCE II pilot study.
Abbas Ali QayyumSabina FrljakMorten JuhlGregor PoglajenGregor ZemljičlAndraz CerarThomas LitmanAnnette EkblondMandana Haack-SørensenLisbeth Drozd HøjgaardJens KastrupBojan VrtovecPublished in: ESC heart failure (2024)
Intramyocardial injections of allogeneic CSCC_ASC in patients with chronic non-ischaemic HFrEF was safe and improved LVESV, LVEF, NYHA class, and self-reported health compared with standard care group.
Keyphrases
- heart failure
- healthcare
- public health
- bone marrow
- stem cell transplantation
- palliative care
- mental health
- quality improvement
- left ventricular
- health information
- platelet rich plasma
- nlrp inflammasome
- ultrasound guided
- pain management
- hematopoietic stem cell
- high dose
- acute heart failure
- health promotion
- health insurance